Arlington Capital Partners Announces Investment in Advanced Health Media

WASHINGTON, DC, February 6, 2007 – Arlington Capital Partners (, a Washington, DC-based private equity firm, today announced an investment in privately held Advanced Health Media, LLC ( (“AHM”), in partnership with the company’s existing management team. Headquartered in Union, New Jersey, AHM is the leading U.S. provider of regulatory compliance management systems and related sales logistics services to the pharmaceutical and biotechnology industries. AHM’s proprietary PFX™ System provides enterprise level capabilities including meeting planning workflow, speaker eligibility management, and financial controls, as well as compliance management, documentation and reporting.

“Over the last decade, regulatory agencies have introduced landmark guidelines and legislation pertaining to the interaction between pharmaceutical companies and healthcare providers,” said Peter Manos, a Partner at Arlington Capital Partners. “These changes have caused pharmaceutical companies to reexamine their sales and marketing practices, and implement new corporate policies and procedures designed to ensure compliance with the new industry standards. As such, these developments have created demand for AHM’s innovative products and services, which enables pharmaceutical companies to comply with the heightened federal and state regulations.”

John Bates of Arlington Capital Partners noted: “Our interest in AHM rose primarily out of the breadth of the company’s proprietary logistics and compliance management system. The software has enabled AHM to efficiently gather data and deliver information to its customers to meet their communications and management objectives while helping them comply with regulatory requirements through auditable solutions. Given the breadth, scale and experience of the management team, AHM has developed an industry leading reputation for delivering strong results and a complete solution.”

AHM will continue to be led by its Chief Executive Officer, Kevin McMurtry, who, in conjunction with AHM’s management team, has been responsible for the company’s tremendous growth since it was founded in 1999. Kevin McMurtry is a leading expert in pharmaceutical sales and compliance management solutions and was named as an Entrepreneur of the Year in the category of Business Services by Ernst & Young.

Kevin McMurtry commented about the new relationship with Arlington: “We are extremely pleased to be entering into a partnership with Arlington. Their depth of experience and expertise in business services and technology, especially in federally regulated industries, makes Arlington an ideal partner for AHM. As the compliance requirements of the pharmaceutical industry continue to evolve, we believe that Arlington’s knowledge base, relationships and significant capital will serve our Company well” said McMurtry. “With Arlington’s support, our Company will increase our investment in technology R&D and pursue strategic acquisition opportunities that will further enhance and expand our service offerings to our clients.”

About Arlington Capital Partners

Arlington Capital Partners ( is a Washington, DC-based private equity fund with over $1 billion of committed capital focused on middle market buyout investment opportunities in growth industries including: aerospace/defense, federal and commercial IT and engineering services, media, education & training, healthcare services and business services & outsourcing. The firm’s professionals have a unique combination of operating and private equity experience that enables Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their company’s position as leading competitors in their field.

SOURCE: Arlington Capital Partners